2015-2025 Global Neurological Disorder Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

July 2024 | 104 pages | ID: 25B4131485B7EN
99Strategy

Abstracts

SUMMARY

The global Neurological Disorder Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd

Key Types

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Key End-Use

• Hospital
• Clinic
• Home

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaNeurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table America Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Neurological Disorder Drugs Production Forecast
Figure Global Neurological Disorder Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Neurological Disorder Drugs Forecast by Type
Table Global Neurological Disorder Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Neurological Disorder Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Neurological Disorder Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Neurological Disorder Drugs Forecast by End-Use (2020E-2025F)
Table Global Neurological Disorder Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Neurological Disorder Drugs Forecast by Region (2020E-2025F)
Table Global Neurological Disorder Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Neurological Disorder Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Novartis AG
  9.1.1 Novartis AG Profile
Table Novartis AG Overview List
  9.1.2 Novartis AG Products & Services
  9.1.3 Novartis AG Company Dynamics & News
  9.1.4 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 GlaxoSmithKline plc
  9.2.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
  9.2.2 GlaxoSmithKline plc Products & Services
  9.2.3 GlaxoSmithKline plc Company Dynamics & News
  9.2.4 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Merck & Co.
  9.3.1 Merck & Co. Profile
Table Merck & Co. Overview List
  9.3.2 Merck & Co. Products & Services
  9.3.3 Merck & Co. Company Dynamics & News
  9.3.4 Merck & Co. Business Operation Conditions
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Bayer AG
  9.4.1 Bayer AG Profile
Table Bayer AG Overview List
  9.4.2 Bayer AG Products & Services
  9.4.3 Bayer AG Company Dynamics & News
  9.4.4 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 AstraZeneca
  9.5.1 AstraZeneca Profile
Table AstraZeneca Overview List
  9.5.2 AstraZeneca Products & Services
  9.5.3 AstraZeneca Company Dynamics & News
  9.5.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Boehringer Ingelheim GmbH
  9.6.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
  9.6.2 Boehringer Ingelheim GmbH Products & Services
  9.6.3 Boehringer Ingelheim GmbH Company Dynamics & News
  9.6.4 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Teva Pharmaceutical Industries Ltd
  9.7.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
  9.7.2 Teva Pharmaceutical Industries Ltd Products & Services
  9.7.3 Teva Pharmaceutical Industries Ltd Company Dynamics & News
  9.7.4 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Neurological Disorder Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Neurological Disorder Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Neurological Disorder Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Neurological Disorder Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Neurological Disorder Drugs Market Concentration Ratio in 2020E
Figure America Neurological Disorder Drugs Market Concentration Ratio in 2020E
Figure Asia Neurological Disorder Drugs Market Concentration Ratio in 2020E
Figure Oceania Neurological Disorder Drugs Market Concentration Ratio in 2020E
Figure Africa Neurological Disorder Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON NEUROLOGICAL DISORDER DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 NEUROLOGICAL DISORDER DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Neurological Disorder Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Neurological Disorder Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Neurological Disorder Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Neurological Disorder Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Neurological Disorder Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Neurological Disorder Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Neurological Disorder Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Neurological Disorder Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Neurological Disorder Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Neurological Disorder Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Neurological Disorder Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Neurological Disorder Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Neurological Disorder Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Neurological Disorder Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Neurological Disorder Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Neurological Disorder Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Neurological Disorder Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaNeurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Neurological Disorder Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Neurological Disorder Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Neurological Disorder Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Neurological Disorder Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Neurological Disorder Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Neurological Disorder Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Neurological Disorder Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Neurological Disorder Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Neurological Disorder Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Neurological Disorder Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Neurological Disorder Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Neurological Disorder Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Neurological Disorder Drugs Consumption Volume Share by Region in 2025 (Volume)